Latest Blog Posts
Affected by California’s Wildfires? Contact Ferrer, Poirot & Wansbrough.
| November 16th, 2018
Wildfires have already destroyed more than 130,000 acres of land in California, causing an unprecedented death toll that continues to rise. Many residents in affected areas are still missing and many others have had their homes and property severely damaged or completely destroyed. Pacific Gas & Electric (PG&E), a natural gas and electricity provider to
Read MoreAvoid These 2 Drug Injury Mistakes
| November 13th, 2018
Drug injuries can be painful, disabling, and even fatal. The medications that are supposed to help patients can instead cause new injuries or illnesses that require intensive medical procedures to treat—and those complications are often due to drug companies hiding data concerning potential side effects and medication-related dangers. At Ferrer, Poirot & Wansbrough, our drug
Read MoreFDA Recalls Blood Pressure Medication due to Impurity Linked to Cancer Risk
| November 7th, 2018
The U.S. Food and Drug Administration (FDA) announced late last month that it was recalling the blood pressure medication Irbesartan. According to USA Today, the drug is manufactured by SciGen Pharmaceuticals, but packages will contain labels with brand names of Westminster Pharmaceuticals and Golden State Medical Supply, Inc. (GSMS). Per the FDA, the affected medications
Read MoreFerrer, Poirot & Wansbrough Helps Win $1.25 Million Verdict for Pradaxa Victim
| October 30th, 2018
A federal jury recently awarded $1.25 million to the family of an 84-year-old woman who died after taking Pradaxa after it found that Boehringer Ingelheim Pharmaceuticals Inc. didn’t properly disclose the risks associated with the medication. Drug injury lawyers at Ferrer, Poirot & Wansbrough are proud to have served on the family’s legal counsel during
Read More